$KGKG
KONA GOLD BEVERAGE, INC. Stock $kgkg

$kgkg Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000149315222013266 Filed on May 13, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$995.1K	$462.4K
YoY Change	115.21%	128.85%
Cost Of Revenue	$849.9K	$313.9K
YoY Change	170.73%	115.06%
Gross Profit	$145.3K	$148.5K
YoY Change	-2.18%	164.73%
Gross Profit Margin	14.6%	32.11%
Selling, General & Admin	$939.3K	$569.0K
YoY Change	65.09%	-12.09%
% of Gross Profit	646.68%	383.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$26.18K	$9.907K
YoY Change	164.26%	29.12%
% of Gross Profit	18.02%	6.67%
Operating Expenses	$939.3K	$3.589M
YoY Change	-73.82%	530.71%
Operating Profit	-$794.1K	-$420.5K
YoY Change	88.85%	-28.87%
Interest Expense	$430.9K	$37.34K
YoY Change	1054.01%	880.8%
% of Operating Profit
Other Income/Expense, Net	$3.224K
YoY Change
Pretax Income	-$3.565M	-$1.817M
YoY Change	96.17%	205.43%
Income Tax	-$3.220K	$2.580K
% Of Pretax Income
Net Earnings	-$3.562M	-$1.820M
YoY Change	95.74%	205.84%
Net Earnings / Revenue	-357.9%	-393.49%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	-$3.065K	-$2.260K
COMMON SHARES
Basic Shares Outstanding	1.162B shares	814.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$296.8K	$56.20K
YoY Change	428.1%	203.29%
Cash & Equivalents	$296.8K	$56.20K
Short-Term Investments
Other Short-Term Assets	$28.81K	$7.518K
YoY Change	283.2%	44.86%
Inventory	$1.129M	$861.7K
Prepaid Expenses	$11.37K
Receivables	$94.13K	$111.7K
Other Receivables	$0.00	$14.88K
Total Short-Term Assets	$1.560M	$1.052M
YoY Change	48.34%	19.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$345.4K	$177.0K
YoY Change	95.2%	-62.78%
Goodwill		$0.00
YoY Change
Intangibles	$73.52K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.13K	$6.500K
YoY Change	132.77%	0.0%
Total Long-Term Assets	$1.352M	$2.416M
YoY Change	-44.05%	333.32%
TOTAL ASSETS
Total Short-Term Assets	$1.560M	$1.052M
Total Long-Term Assets	$1.352M	$2.416M
Total Assets	$2.912M	$3.468M
YoY Change	-16.03%	141.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.072M	$257.8K
YoY Change	315.82%	104.01%
Accrued Expenses	$500.9K	$105.0K
YoY Change	376.93%	-92.9%
Deferred Revenue
YoY Change
Short-Term Debt	$652.6K	$1.200M
YoY Change	-45.62%
Long-Term Debt Due	$344.9K	$9.000K
YoY Change	3732.33%	-25.0%
Total Short-Term Liabilities	$4.502M	$4.023M
YoY Change	11.91%	148.7%
LONG-TERM LIABILITIES
Long-Term Debt	$1.376M	$2.808M
YoY Change	-50.99%	54.62%
Other Long-Term Liabilities	$615.3K	$763.6K
YoY Change	-19.42%	184.19%
Total Long-Term Liabilities	$615.3K	$3.571M
YoY Change	-82.77%	71.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.502M	$4.023M
Total Long-Term Liabilities	$615.3K	$3.571M
Total Liabilities	$7.274M	$7.594M
YoY Change	-4.22%	105.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.86M	-$11.10M
YoY Change	78.94%
Common Stock	$14.83K	$8.257K
YoY Change	79.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.362M	-$2.470M
YoY Change
Total Liabilities & Shareholders Equity	$2.912M	$3.468M
YoY Change	-16.03%	141.21%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$3.562M	-$1.820M
YoY Change	95.74%	205.84%
Depreciation, Depletion And Amortization	$26.18K	$9.907K
YoY Change	164.26%	29.12%
Cash From Operating Activities	-$669.5K	-$424.4K
YoY Change	57.76%	63.24%
INVESTING ACTIVITIES
Capital Expenditures	$21.13K	$20.27K
YoY Change	4.27%	-220.05%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$1.286M
YoY Change	-100.0%	-63133.82%
Cash From Investing Activities	-$21.13K	-$1.306M
YoY Change	-98.38%	8701.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$283.6K	$1.671M
YoY Change	-83.02%	549.73%
NET CHANGE
Cash From Operating Activities	-$669.5K	-$424.4K
Cash From Investing Activities	-$21.13K	-$1.306M
Cash From Financing Activities	$283.6K	$1.671M
Net Change In Cash	-$407.0K	-$59.97K
YoY Change	578.76%	238.8%
FREE CASH FLOW
Cash From Operating Activities	-$669.5K	-$424.4K
Capital Expenditures	$21.13K	$20.27K
Free Cash Flow	-$690.6K	-$444.7K
YoY Change	55.32%	82.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001802546
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	KGKG	Financing Cost Expense FinancingCostExpense		usd
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q1	KGKG	Gain On Change In Fair Value Of Derivative Liabilities GainOnChangeInFairValueOfDerivativeLiabilities		usd
CY2022Q1	KGKG	Interest Expense Related To Warrants On Convertible Debt InterestExpenseRelatedToWarrantsOnConvertibleDebt		usd
CY2022Q1	KGKG	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition		usd
CY2021Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2022Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
CY2022Q1	KGKG	Payments For Proceeds From In Intellectual Property PaymentsForProceedsFromInIntellectualProperty		usd
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2021Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2021Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022Q1	KGKG	Proceeds From Ppp Notes Payable ProceedsFromPppNotesPayable		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2021Q1	KGKG	Common Shares Issued On Conversion Of Debentures And Accrued Interest CommonSharesIssuedOnConversionOfDebenturesAndAccruedInterest		usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2022Q1	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022Q1	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2022Q1	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	000-56230
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	KONA GOLD BEVERAGE, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-5175120
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	746 North Drive
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Melbourne
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32934
CY2022Q1	dei	City Area Code CityAreaCode	(844)
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	714-2224
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2022Q1	dei	Trading Symbol TradingSymbol	KGKG
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1573544060	shares
CY2022Q1	us-gaap	Cash Cash	296792	usd
CY2021Q4	us-gaap	Cash Cash	703825	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3560	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	11926	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	94129	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15993	usd
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	150000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	150000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	1129292	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	574811	usd
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11365	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	278707	usd
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	28809	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	30373	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	1560387	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1603709	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	345424	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348037	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	917745	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	966955	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	73516	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	75955	usd
CY2022Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	15125	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	15125	usd
CY2022Q1	us-gaap	Assets Assets	2912197	usd
CY2021Q4	us-gaap	Assets Assets	3009781	usd
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1072181	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	541123	usd
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	279583	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	329583	usd
CY2022Q1	us-gaap	Loans Payable Current LoansPayableCurrent	167412	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	7974	usd
CY2022Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	177500	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	6000	usd
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	56776	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	60000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	221344	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	213837	usd
CY2022Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	652563	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	849933	usd
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1875000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2121000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4502359	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4129450	usd
CY2022Q1	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1352651	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1525651	usd
CY2022Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	23344	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	25338	usd
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	615317	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	615317	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	780532	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	838883	usd
CY2022Q1	us-gaap	Liabilities Liabilities	7274203	usd
CY2021Q4	us-gaap	Liabilities Liabilities	7134639	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5700250	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	10	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	10	usd
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1482788393	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1482788393	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1004709546	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1004709546	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	14828	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10047	usd
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000	shares
CY2022Q1	KGKG	Common Stock Issuable Shares CommonStockIssuableShares	170000000	shares
CY2021Q4	KGKG	Common Stock Issuable Shares CommonStockIssuableShares	170000000	shares
CY2022Q1	KGKG	Common Stock Issuable CommonStockIssuable	1386497	usd
CY2021Q4	KGKG	Common Stock Issuable CommonStockIssuable	1386497	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14098394	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10778761	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19861735	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16300173	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-4362006	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4124858	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2912197	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3009781	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	995131	usd
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	462408	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	849876	usd
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	313920	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	145255	usd
CY2021Q1	us-gaap	Gross Profit GrossProfit	148488	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	939336	usd
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	568980	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-794081	usd
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-420492	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	430895	usd
CY2021Q1	us-gaap	Interest Expense InterestExpense	37339	usd
CY2021Q1	KGKG	Financing Cost Expense FinancingCostExpense	1093571	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1793000	usd
CY2021Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-265866	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-546810	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3224	usd
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2275	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3561562	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1819543	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1162096383	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	814735237	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4124858	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3189414	usd
CY2022Q1	KGKG	Common Stock Issued With Note Payable Received As Debt Discount Value CommonStockIssuedWithNotePayableReceivedAsDebtDiscountValue	135000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3561562	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-4362006	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-2857654	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	613809	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	270900	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1052571	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1819543	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-2739917	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3561562	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-1819543	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	23744	usd
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9907	usd
CY2022Q1	KGKG	Rightofuse Asset Amortization RightofuseAssetAmortization	49210	usd
CY2021Q1	KGKG	Rightofuse Asset Amortization RightofuseAssetAmortization	37023	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	367845	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2439	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-8366	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-546810	usd
CY2022Q1	KGKG	Gain On Change In Fair Value Of Derivative Liabilities GainOnChangeInFairValueOfDerivativeLiabilities	-1793000	usd
CY2021Q1	KGKG	Interest Expense Related To Warrants On Convertible Debt InterestExpenseRelatedToWarrantsOnConvertibleDebt	1052571	usd
CY2021Q1	KGKG	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition	270900	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	69770	usd
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	122184	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	554481	usd
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	201148	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-267342	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1564	usd
CY2021Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1946	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	571666	usd
CY2021Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	59730	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-50000	usd
CY2021Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	61458	usd
CY2021Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	265866	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-48945	usd
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-37023	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-669504	usd
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-424389	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21131	usd
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20265	usd
CY2021Q1	KGKG	Payments For Proceeds From Goodwill PaymentsForProceedsFromGoodwill	1275938	usd
CY2021Q1	KGKG	Payments For Proceeds From In Intellectual Property PaymentsForProceedsFromInIntellectualProperty	9953	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21131	usd
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1306156	usd
CY2022Q1	KGKG	Repayments Of Long Term Lines Of Credits RepaymentsOfLongTermLinesOfCredits	1500	usd
CY2021Q1	KGKG	Repayments Of Long Term Lines Of Credits RepaymentsOfLongTermLinesOfCredits	3000	usd
CY2022Q1	KGKG	Proceeds From Payment Of Acquisition Obligation ProceedsFromPaymentOfAcquisitionObligation	3224	usd
CY2021Q1	KGKG	Proceeds From Payment Of Acquisition Obligation ProceedsFromPaymentOfAcquisitionObligation	-642284	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1899	usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	292219	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1994	usd
CY2021Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	913809	usd
CY2021Q1	KGKG	Proceeds From Ppp Notes Payable ProceedsFromPppNotesPayable	117487	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	283602	usd
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1670578	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-407033	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-59967	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	703825	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	113168	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	296792	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53201	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	130	usd
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	17205	usd
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	135000	usd
CY2022Q1	KGKG	Common Shares Issued On Conversion Of Debentures And Accrued Interest CommonSharesIssuedOnConversionOfDebenturesAndAccruedInterest	3189414	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-4362006	usd
CY2022Q1	us-gaap	Cash Cash	296792	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3561562	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-669504	usd
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zRZY4w9Tea6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zdiRlCGS6d0e">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	KGKG	Sales Percentage SalesPercentage	0.03	pure
CY2022Q1	KGKG	Sales Returns And Allowances SalesReturnsAndAllowances	35100	usd
CY2021Q1	KGKG	Sales Returns And Allowances SalesReturnsAndAllowances	23413	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	995131	usd
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	462408	usd
CY2022Q1	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1.15	pure
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	995131	usd
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	462408	usd
CY2022Q1	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1.15	pure
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1695611077	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	964533357	shares
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	52419	usd
CY2021Q1	us-gaap	Advertising Expense AdvertisingExpense	10300	usd
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zudF12U3Co" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zEnZHBzBjO76">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s cash balances on deposit with banks are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20220331_z1wz0g60EVe9" title="Cash FDIC insured amount">250,000</span>. Generally, the Company’s policy is to minimize borrowing costs by immediately applying cash receipts to borrowings against its credit facility. From time to time, however, the Company may be exposed to risk for the amounts of funds held in bank accounts in excess of the FDIC limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gross sales.</i> During the three months ended March 31, 2022, the Company reported no customers that accounted for more than <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zjIRLOx6CWmb">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of gross sales. During the three months ended March 31, 2021, the Company reported one customer represented <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zMsYF19Oh444">12</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Company’s gross sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of March 31, 2022, the Company had no customers that accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zT8TUla4MZTe">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% or more of its gross accounts receivable. As of December 31, 2021, the Company had accounts receivable from two customers that comprised <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_za6GPmjfZPWi">60</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of its gross accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Co-Packers. </i>The raw materials used in the production of the Company’s products are obtained by the Company’s co-packers and consist primarily of materials such as the flavors, caffeine, sugars or sucralose, taurine, vitamins, CBD, and hemp seed protein contained in its beverages, the bottles in which its beverages are packaged, and the labeling on the outside of its beverages. These principal raw materials are subject to price and availability fluctuations. The Company currently relies on a few key co-packers, which in turn rely on a few key suppliers. The Company continually endeavors to have back-up co-packers, which co-packers would in turn depend on their third-party suppliers to supply certain of the flavors and concentrates that are used in the Company’s beverages. The Company is also dependent on these co-packers to negotiate arrangements with their existing suppliers that would enable the Company to obtain access to certain of such concentrates or flavor formulas under certain extraordinary circumstances. Additionally, in a limited number of cases, the Company’s co-packers may have contractual restrictions with their suppliers or the Company’s co-packers may need to obtain regulatory approvals and licenses that may limit the co-packers’ ability to enter into agreements with alternative suppliers. Contractual restrictions in the agreements the Company has with certain distributors may also limit the Company’s ability to enter into agreements with alternative distributors. The Company believes that a satisfactory supply of co-packers will continue to be available at competitive prices, although there can be no assurance in this regard. The Company continually endeavors to contract with additional beverage vendors to ensure the Company has adequate inventory. The Company believes that a satisfactory supply of vendors will continue to be available at competitive prices, although there can be no assurance in this regard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the period ended March 31, 2022, the Company’s largest three vendors accounted for approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zrL90FhVl1I6" title="Concentration risk, percentage">27</span>%, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zDQJMmjXKex1" title="Concentration risk, percentage">12</span>%, and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--VendorThreeMember_z8dHwtVmVYS5" title="Concentration risk, percentage">10</span>% of all purchases, respectively. During the period ended March 31, 2021, the Company’s largest four vendors accounted for approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zfHIfea48li3" title="Concentration risk, percentage">29</span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zlJec2fJ0ew" title="Concentration risk, percentage">16</span>%, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--VendorThreeMember_zWqrXcna9D2e" title="Concentration risk, percentage">11</span>%, and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--VendorFourMember_zMe8Y41My5Kh" title="Concentration risk, percentage">10</span>% of all purchases, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable.</i> As of March 31, 2022, one vendor accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorOneMember_zbW3zNMPpSvk" title="Concentration risk, percentage">14</span>% of the total accounts payable. As of December 31, 2021, four vendors accounted for more than 10% the total accounts payable. The Company’s largest four vendors accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorOneMember_zvXdB4ZncxG5" title="Concentration risk, percentage">20</span>%, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zdfOlNOUygA8" title="Concentration risk, percentage">14</span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zwLUp2OeRK1j" title="Concentration risk, percentage">12</span>%, and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zbcRhicF17gf" title="Concentration risk, percentage">11</span>% of the total accounts payable, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	451318	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	70592	usd
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	677974	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	504219	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	1129292	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	574811	usd
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	150000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	150000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	473289	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	452158	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	127865	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	104121	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	345424	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348037	usd
CY2022Q1	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	85340	usd
CY2021Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	85340	usd
CY2022Q1	KGKG	Finite Lived Gross Website Development Trademarks FiniteLivedGrossWebsiteDevelopmentTrademarks	12200	usd
CY2021Q4	KGKG	Finite Lived Gross Website Development Trademarks FiniteLivedGrossWebsiteDevelopmentTrademarks	12200	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24024	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21585	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	73516	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	75955	usd
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2439	usd
CY2021Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2247	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	7315	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9754	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	9754	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9754	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9754	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	27185	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	73516	usd
CY2022Q1	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	1530151	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	1531651	usd
CY2022Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	177500	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	6000	usd
CY2022Q1	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1352651	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1525651	usd
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	132781	usd
CY2022Q1	us-gaap	Notes Payable NotesPayable	190756	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	33312	usd
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	167412	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7974	usd
CY2022Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	23344	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	25338	usd
CY2022Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1875000	usd
CY2022Q1	KGKG	Derivative Liabilities Activity DerivativeLiabilitiesActivity	2039000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2121000	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2121000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1793000	usd
CY2022Q1	KGKG	Gain On Extinguishment Of Derivative Liabilities GainOnExtinguishmentOfDerivativeLiabilities	2039000	usd
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1875000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	49211	usd
CY2021Q1	us-gaap	Lease Cost LeaseCost	37023	usd
CY2021Q4	KGKG	Operating Lease Liabilities Right Of Use Asset OperatingLeaseLiabilitiesRightOfUseAsset	966955	usd
CY2022Q1	KGKG	Operating Leases OperatingLeases	49211	usd
CY2022Q1	KGKG	Operating Lease Liabilities Right Of Use Asset OperatingLeaseLiabilitiesRightOfUseAsset	917745	usd
CY2021Q4	KGKG	Lease Liabilities LeaseLiabilities	1052720	usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	25481	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1027239	usd
CY2022Q1	KGKG	Increase In Operating Lease IncreaseInOperatingLease	1899	usd
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	48944	usd
CY2022Q1	us-gaap	Lease Deposit Liability LeaseDepositLiability	1001875	usd
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	23581	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	978294	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	221344	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	780532	usd
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M3D
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1000	pure
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0209	pure
CY2022Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	221344	usd
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	282347	usd
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	262715	usd
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	261083	usd
CY2022Q1	KGKG	Lessee Operating Lease Liability Payments Due Four And After Year Four LesseeOperatingLeaseLiabilityPaymentsDueFourAndAfterYearFour	208432	usd
CY2022Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1235921	usd
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	234045	usd
CY2022Q1	KGKG	Present Value Of Net Minimum Lease Payments PresentValueOfNetMinimumLeasePayments	1001876	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	221344	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	780532	usd
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1482788393	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1482788393	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1004709546	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1004709546	shares
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1386497	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1386497	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	170000000	shares
CY2021Q4	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.03
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	170000000	shares
CY2022Q1	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.03
CY2022Q1	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	170000000	shares
CY2022Q1	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercisable Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisablePrice	0.03
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	170000000	shares
CY2022Q1	KGKG	Class Of Warrant Or Right Number Of Use Ful Life ClassOfWarrantOrRightNumberOfUseFulLife	P2Y1M2D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice	0.03
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	170000000	shares
CY2022Q1	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.03
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.0076

Files In Submission

Name	View Source	Status
0001493152-22-013266-index-headers.html	Edgar Link	pending
0001493152-22-013266-index.html	Edgar Link	pending
0001493152-22-013266.txt	Edgar Link	pending
0001493152-22-013266-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
kgkg-20220331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
kgkg-20220331_cal.xml	Edgar Link	unprocessable
kgkg-20220331_def.xml	Edgar Link	unprocessable
kgkg-20220331_lab.xml	Edgar Link	unprocessable
kgkg-20220331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KGKG
KONA GOLD BEVERAGE, INC. Stock $kgkg

2022 Q1 Form 10-Q Financial Statement

#000149315222013266 Filed on May 13, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KGKG KONA GOLD BEVERAGE, INC. Stock $kgkg

2022 Q1 Form 10-Q Financial Statement

#000149315222013266 Filed on May 13, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KGKG
KONA GOLD BEVERAGE, INC. Stock $kgkg